“To Determine the Frequency of Biochemical Adverse Effects in Patients on Meglumine Antimoniate Treatment for Cutaneous Leishmaniasis” (2024) Medical Forum Monthly, 30(9). Available at: https://medicalforummonthly.com/index.php/mfm/article/view/3872 (Accessed: 26 December 2025).